Cite
HARVARD Citation
Glicksman, R. et al. (2020). [18F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial. BMJ open. 10 (4), p. . [Online].